Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye

Genetic Variants Associated with Severe Hypertriglyceridemia: LPL, APOC2, APOA5, GPIHBP1, LMF1, and APOE

(2023) Amir Hossein Abedi   Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Is Genetic Testing in Hypertriglyceridemia Useful?

(2022) Robert A. Hegele   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

(2021) Ioanna Gouni-Berthold et al.   Lancet Diabetes & Endocrinology

Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic

(2020) José Rioja et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Genetics of Hypertriglyceridemia

(2020) Jacqueline S. Dron et al.   Frontiers in Endocrinology

Measurement of apolipoprotein B levels helps in the identification of patients at risk for hypertriglyceridemic pancreatitis

(2020) Kristen M. Gonzales et al.   Journal of Clinical Lipidology

Severe hypertriglyceridemia is primarily polygenic

(2018) Jacqueline S. Dron et al.   Journal of Clinical Lipidology

Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease

(2017) Amit V. Khera et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemia

(2016) Isabel De Castro-Orós et al.   Journal of Clinical Lipidology

Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach

(2016) Weerapan Khovidhunkit et al.   Journal of Clinical Lipidology

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Prevalence of dyslipidemia and associated risk factors in Turkish adults

(2014) Fahri Bayram et al.   Journal of Clinical Lipidology

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

(2014) Ron Do et al.   NATURE

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

(2013) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia

(2012) R. P. Surendran et al.   JOURNAL OF INTERNAL MEDICINE

Resequencing the Apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia

(2011) D. Evans et al.   ATHEROSCLEROSIS

Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population

(2010) S. H. Ley et al.   CLINICAL CHEMISTRY

Modulation of phenotypic expression of APOA5 Q97X and L242P mutations

(2009) S. Charrière et al.   ATHEROSCLEROSIS

Plasma lipoproteins: genetic influences and clinical implications

(2009) Robert A. Hegele   NATURE REVIEWS GENETICS

Effects of Six APOA5 Variants, Identified in Patients With Severe Hypertriglyceridemia, on In Vitro Lipoprotein Lipase Activity and Receptor Binding

(2008) B. Dorfmeister et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia

(2008) Jian Wang et al.   Nature clinical practice. Cardiovascular medicine